We are live on ! Find out more
VYNT

Vyant Bio

Delisted

VYNT was delisted on the 12th of May, 2023.

23 hedge funds and large institutions have $3.66M invested in Vyant Bio in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

2.41% less ownership

Funds ownership: 17.23% → 14.82% (-2.4%)

12% less funds holding

Funds holding: 26 → 23 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

73% less capital inflows, than outflows

Capital inflows: $276K | Capital outflows: $1.01M

Holders
23
Holders Change
-3
Holders Change %
-11.54%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
7
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

VYNT Hedge Fund Activity: Q2 2018 in Review

23 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in Vyant Bio (VYNT) for Q2 2018, worth a combined $3.66M — down 53% from $7.88M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VYNT and 2 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $107K. The largest seller was Stonepine Capital Management, cutting an estimated $384K.

  • 23 institutional investors held Vyant Bio (VYNT) as of Q2 2018, down from 26 in Q1 2018.
  • Funds reported $3.66M of Vyant Bio stock for Q2 2018, down 53% quarter-over-quarter.
  • 2 funds opened new Vyant Bio positions in Q2 2018 and 5 closed out, a net change of -3 holders.
  • The largest Vyant Bio buyer in Q2 2018 was Renaissance Technologies, an estimated $107K added.
  • The largest Vyant Bio seller in Q2 2018 was Stonepine Capital Management, an estimated $384K sold.

Based on aggregated 13F filings for Q2 2018.